M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Phase 2

Recruiting

Conditions: T Acute Lymphoblastic Leukemia
T Lymphoblastic Lymphoma

Interventions: Drug: Cyclophosphamide
Drug: Cytarabine
Drug: Dexamethasone
Drug: Doxorubicin Hydrochloride
Drug: Mercaptopurine
Drug: Methotrexate
Drug: Nelarabine
Drug: Pegaspargase
Drug: Prednisone
Drug: Venetoclax
Drug: Vincristine Sulfate

First Posted Date: 2007-07-16

Last Posted Date: 2024-12-16

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 160

Registration Number: NCT00501826

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Aspirin in Patients With Myocardial Infarction and Thrombocytopenia

Phase 3

Terminated

Conditions: Thrombocytopenia
Myocardial Infarction

Interventions: Drug: Aspirin

First Posted Date: 2007-07-16

Last Posted Date: 2012-08-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 5

Registration Number: NCT00501345

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Measurement of Pain and Other Symptoms of Non-Small Cell Lung Cancer (NSCLC) Patients Following Thoracic Surgery

Completed

Conditions: Lung Cancer

Interventions: Behavioral: Interactive Voice Response (IVR)
Behavioral: Questionnaire

First Posted Date: 2007-07-16

Last Posted Date: 2011-11-08

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 127

Registration Number: NCT00501319

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer

Phase 2

Completed

Conditions: Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer

Interventions: Drug: Carboplatin
Drug: GM-CSF (Sargramostim)
Drug: Interferon Gamma

First Posted Date: 2007-07-16

Last Posted Date: 2012-08-07

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 59

Registration Number: NCT00501644

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Tissue Repair in Stem Cell Transplant Recipients

Not Applicable

Terminated

Conditions: Graft-Versus-Host Disease

Interventions: Drug: Filgrastim

First Posted Date: 2007-07-16

Last Posted Date: 2012-08-07

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 2

Registration Number: NCT00501228

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Genetic Susceptibility in Migrant Farmworker Children

Completed

Conditions: Epidemiology

Interventions: Behavioral: Interview

First Posted Date: 2007-07-16

Last Posted Date: 2013-04-04

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 768

Registration Number: NCT00501280

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes

Completed

Conditions: Multiple Endocrine Neoplasia

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-16

Last Posted Date: 2020-11-18

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 133

Registration Number: NCT00501449

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Physical Activity After Endometrial Cancer

Active, not recruiting

Conditions: Endometrial Cancer

Interventions: Behavioral: Personalized Exercise Program
Behavioral: Questionnaire
Behavioral: Suggested Exercise Program

First Posted Date: 2007-07-16

Last Posted Date: 2020-12-31

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 326

Registration Number: NCT00501761

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Pain Quantification and Pain Management in Interventional Radiology (IR)

Completed

Conditions: Pain

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-13

Last Posted Date: 2012-08-02

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 374

Registration Number: NCT00500942

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Cardiomyopathy Tissue Bank in a Cancer Population

Conditions: Heart Disease

Interventions: Procedure: Blood Sample

First Posted Date: 2007-07-13

Last Posted Date: 2020-01-27

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 1000

Registration Number: NCT00500734

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy